XTALPI (02228) has issued a corporate announcement revealing that its board chairman, executive director, and co-founder, Dr. Wen Shuhao, intends to purchase additional ordinary shares of the company on the open market.

Dr. Wen's decision is driven by his confidence in the group's future development prospects and his belief in the company's long-term investment value, with the planned acquisitions set to take place before the end of October 2026. The share purchases will be funded entirely from his own resources.

These acquisitions must adhere to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, along with other applicable laws, regulations, relevant codes, and the company's internal control and securities trading policies. Under the share increase plan, Dr. Wen has set a total consideration cap of no more than HK$32 million for the combined acquisitions. Each share purchase will be executed at prevailing market prices at the time of the transaction. The company itself will not participate in or provide any financial assistance for the share increase plan.